日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unveiling radiobiological traits and therapeutic responses of BRAFV600E-mutant colorectal cancer via patient-derived organoids

通过患者来源的类器官揭示 BRAFV600E 突变结直肠癌的放射生物学特征和治疗反应

Peiyuan Mu #, Shaobo Mo #, Xingfeng He, Hui Zhang, Tao Lv, Ruone Xu, Luoxi He, Fan Xia, Shujuan Zhou, Yajie Chen, Yaqi Wang, Lijun Shen, Juefeng Wan, Lili Huang, Weiqing Lu, Xinyue Liang, Xiaomeng Li, Ping Lu, Junjie Peng, Guoqiang Hua, Kewen Hu, Zhen Zhang, Yan Wang1

SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma

SNHG17 通过重置 PGK1 的磷酸化修饰来改变无氧糖酵解,从而促进胰腺导管腺癌中的促肿瘤巨噬细胞形成

Jiayu Lin #, Yihao Liu #, Pengyi Liu #, Wenxin Qi #, Jia Liu #, Xingfeng He, Qian Liu, Zehua Liu, Jingxin Yin, Jiewei Lin, Haili Bao, Jianhong Lin

Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer

患者来源的类器官作为转移性结直肠癌药物筛选的平台

Xingfeng He, Yan Jiang, Long Zhang, Yaqi Li, Xiang Hu, Guoqiang Hua, Sanjun Cai, Shaobo Mo, Junjie Peng

Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis

过去十年膀胱癌卡介苗免疫疗法的新兴趋势:文献计量学和可视化分析

Chen, Xingfeng; He, Fang; Zhang, Wenjin; Fu, Yao; Cao, Zhiqin

Assay establishment and validation of a high-throughput organoid-based drug screening platform

基于高通量类器官药物筛选平台的检测方法建立与验证

Xiaomeng Li #, Guoxiang Fu #, Long Zhang #, Ruoyu Guan, Peiyuan Tang, Jialing Zhang, Xinxin Rao, Shengzhi Chen, Xiaoya Xu, Yi Zhou, Yun Deng, Tao Lv, Xingfeng He, Shaobo Mo, Peiyuan Mu, Jianjun Gao, Guoqiang Hua

Patient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy

来自伴有肝转移的结肠直肠癌的患者来源的类器官揭示肿瘤异质性并预测对化疗的反应

Shaobo Mo, Peiyuan Tang, Wenqin Luo, Long Zhang, Yaqi Li, Xiang Hu, Xiaoji Ma, Yikuan Chen, Yichao Bao, Xingfeng He, Guoxiang Fu, Xiaoya Xu, Xinxin Rao, Xiaomeng Li, Ruoyu Guan, Shengzhi Chen, Yun Deng, Tao Lv, Peiyuan Mu, Qiang Zheng, Simin Wang, Fangqi Liu, Yiwei Li, Weiqi Sheng, Dan Huang, Chen H

Ruxolitinib protects lipopolysaccharide (LPS)-induced sepsis through inhibition of nitric oxide production in mice

鲁索替尼通过抑制小鼠一氧化氮的产生来预防脂多糖 (LPS) 诱发的脓毒症

Li Li, Xingfeng He, Xingtong Wang, Yu Sun, Guosheng Wu, He Fang, Chen Wang, Pengfei Luo, Zhaofan Xia